Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7420130
Reference Type
Journal Article
Title
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
Author(s)
Sterkens, A; Lambert, J; Bervoets, A; ,
Year
2021
Is Peer Reviewed?
Yes
Journal
Clinical and Experimental Medicine
ISSN:
1591-8890
EISSN:
1591-9528
Publisher
SPRINGER-VERLAG ITALIA SRL
Location
MILAN
Language
English
PMID
33386567
DOI
10.1007/s10238-020-00673-w
Web of Science Id
WOS:000604092200002
URL
http://link.springer.com/10.1007/s10238-020-00673-w
Exit
Abstract
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, including eyelashes and eyebrows, or even the entire body. The exact pathology is not yet known, but the most described theory is a collapse of the immune privilege system, which can be found in some specific regions of the body. Different treatment options, local and systemic, are available, but none of them have been proven to be effective in the long term as well for every treatment there should be considered for the possible side effects. In many cases, treated or non-treated, relapse often occurs. The prognosis is uncertain and is negatively influenced by the subtypes alopecia totalis and alopecia universalis and characteristics such as associated nail lesions, hair loss for more than 10 years and a positive familial history. The unpredictable course of the disease also makes it a mental struggle and AA patients are more often associated with depression and anxiety compared to the healthy population. Research into immunology and genetics, more particularly in the field of dendritic cells (DC), is recommended for AA as there is evidence of the possible role of DC in the treatment of other autoimmune diseases such as multiple Sclerosis and cancer. Promising therapies for the future treatment of AA are JAK-STAT inhibitors and PRP.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity